Drug profile · INN
acetic acid, glacial
TRIDESILON
acetic acid, glacial (TRIDESILON) is an FDA-listed pharmaceutical active ingredient. Route of administration: irrigation, urethral. Current US regulatory status: approved.
Drug details — acetic acid, glacial
- US status
- approved
- Class
- —
- Route
- IRRIGATION, URETHRAL
- Patents
- 20
- Programs
- 12
- Data quality
- 0.84
Quick answer
acetic acid, glacial (TRIDESILON) is an FDA-listed pharmaceutical active ingredient. Route of administration: irrigation, urethral. Current US regulatory status: approved.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related patents
-
US 12419877
Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof
granted -
US 11690836
Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof
granted -
US 11524939
Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino} acetic acid
granted -
US 11420929
Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists
granted -
US 11065237
Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof
granted -
US 11008360
Indoleacetic acid derivative and preparation method and pharmaceutical use thereof
granted -
US 10968231
Substituted cyclyl-acetic acid derivatives for the treatment of metabolic disorders
granted -
US 10947180
Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists
granted -
US 10792274
Dehydroacetic acid (DHAA) and derivative for uses in treating cancer
granted -
US 10596158
Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof
granted -
US 10471066
Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists
granted -
US 10150734
Solid forms of 2-(5-(3-fluorophenyl)-3-hydroxypicolinamido)acetic acid, compositions, and uses thereof
granted -
US 10149842
Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof
granted -
US 9987262
Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof
granted -
US 2018036436
ETHYLENEDIAMINETETRAACETIC ACID BIS(AMIDE) DERIVATIVES AND THEIR RESPECTIVE COMPLEXES WITH MN(II) ION FOR USE AS MRI CONTRAST AGENT
granted -
US 9855274
Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists
granted -
US 9701636
Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof
granted -
US 9663481
Phenoxy acetic acids and phenyl propionic acids as PPARδ agonists
granted -
US 9149468
Multicomponent crystals made ([2-amino-6-(4-fluoro-benzylamino)-pyridin-3-yl]-carbamic acid ethyl ester and 2-[2-[(2,6-dichlorphenyl)-amino]-phenyl]-acetic acid
granted -
US 8822467
Biaryl oxyacetic acid compounds
granted
Frequently asked questions
What is acetic acid, glacial?
acetic acid, glacial (TRIDESILON) is an FDA-listed pharmaceutical active ingredient. Route of administration: irrigation, urethral. Current US regulatory status: approved.
What is the brand name for acetic acid, glacial?
TRIDESILON is a marketed brand name for acetic acid, glacial. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of acetic acid, glacial?
acetic acid, glacial has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.